Report overview
Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory failure, renal failure and asthma. According to a World Health Organization (WHO) report published in 2014, around 3.4 million adults in the world die each year due to obesity related issues. Increasing prevalence of obesity among children and adults is posing a threat and developing nations. Effective intervention strategies such as increased physical activity, behavioral and dietary changes are commonly used to control and prevent obesity. Obesity has a major impact on population longevity and health related expense.
This report aims to provide a comprehensive presentation of the global market for Anti-Obesity Prescription, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Obesity Prescription. This report contains market size and forecasts of Anti-Obesity Prescription in global, including the following market information:
Global Anti-Obesity Prescription Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Obesity Prescription Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Obesity Prescription companies in 2022 (%)
The global Anti-Obesity Prescription market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
There is increased use of anti-obesity prescription due to increasing obesity endemic. Sedentary lifestyle and junk food habits, increasing healthcare expenditure and rise in aging population are some of the key factors driving the growth for global anti-obesity prescription market. In addition, increasing healthcare awareness is also fuelling the growth of the global anti-obesity prescription market. However, side effects of anti-obesity drugs, high drug development cost and strict regulatory framework are some of the major factors restraining the growth for the global anti-obesity prescription market.
We surveyed the Anti-Obesity Prescription manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Obesity Prescription Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Obesity Prescription Market Segment Percentages, by Type, 2022 (%)
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
Global Anti-Obesity Prescription Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Obesity Prescription Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Global Anti-Obesity Prescription Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Obesity Prescription Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Obesity Prescription revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Obesity Prescription revenues share in global market, 2022 (%)
Key companies Anti-Obesity Prescription sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Obesity Prescription sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zydus Cadila
Akrimax Pharmaceuticals
Zealand Pharma
Arrowhead Research
Arena Pharmaceuticals
Compellis Pharmaceuticals
Yungjin Pharm
Alpex Pharma
Bridge BioResearch
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Obesity Prescription, market overview.
Chapter 2: Global Anti-Obesity Prescription market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Obesity Prescription manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Obesity Prescription in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Obesity Prescription capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
